EXERCISE OF LISTED OPTIONS

Highlights

  • BluGlass has received approximately $1.66 million from the exercise of its recently listed options (ASX:BLGO), the balance of which expired on 30 November 2022.
  • Additional placement of approximately $250,000 to sophisticated shareholders who applied for amounts greater than their entitlement.

Global semiconductor developer, BluGlass Limited (ASX: BLG) advises it has a raised a total of $1.91 million from the exercise of its recently listed options (ASX:BLGO), the balance of which expired on 30 November.

$1.66 million was received from the exercise of the options at a price of $0.03.

Approximately $250,000 in additional funds and commitments was also received from a group of sophisticated shareholders who applied for amounts greater than their option entitlement. BLG will place shares to these shareholders at $0.03 per share.

BluGlass Chair James Walker said “I would like to thank our loyal shareholders for their ongoing support. These options assist the ongoing operation of our Silicon Valley fab, which has been transformational for the business, speeding development and enhancing product quality. We are already reaping the significant benefits of our captive fab and supply chain, successfully demonstrating feasible reliability of our laser diode products. BluGlass is nearing productisation within large and growing markets, and will utilise this funding to deliver on the businesses goals and launch commercial products to market”.

BluGlass logo
About BluGlass

Developing leading-edge semiconductor manufacturing technology and devices for more than a decade, BluGlass Limited (ASX:BLG) is a leading supplier of GaN laser diode products to the global photonics industry, focused on the industrial, defence, bio-medical, and scientific markets.

Listed on the ASX, BluGlass is one of just a handful of end-to-end GaN laser manufacturers globally. Its operations in Australia and the USA offer cutting-edge, custom laser diode development and manufacturing, from small-batch custom lasers to medium and high-volume off-the-shelf products.

The Company combines its proprietary low temperature, low hydrogen, remote plasma chemical vapour deposition (RPCVD) manufacturing process with advanced device design and fabrication to deliver differentiated laser solutions. With end-to-end capabilities spanning epitaxy, device design, fabrication, and testing, BluGlass is well-positioned to support critical next-generation photonics applications and sovereign supply chains.

For more information, please contact:

Stefanie Winwood
+61293342300 |swinwood@bluglass.com
Jasmine Walters, Automic Markets
+61498209019 |jasmine.walters@automicgroup.com.au
Samuel Samhan, BluGlass CFO
ssamhan@bluglass.com